[ad_1]
- CVS needs more expensive drugs Wall Street Journal
- CVS shares plummet by 7%, as expected, investments in Aetna CNBC have a negative impact
- CVS predicts a horrible 2019 year after signing an agreement between Aetna and Bloomberg for 68 billion dollars
- CVS beats T4 earnings forecast, but guides for lower earnings in 2019 TheStreet.com
- The actions that generate the most movement before marketing: CVS Health, Garmin, Gannett, Apple, etc. CNBC
- View full coverage on Google News
[ad_2]
Source link